Peter Sever
Impact in
-
- Blood Pressure and Hypertension Studies
- Heart Rate Variability and Autonomic Control
- Cardiovascular Health and Disease Prevention
-
- Hormonal Regulation and Hypertension
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Blood Pressure and Hypertension Studies 72
- Heart Rate Variability and Autonomic Control 15
- Renin-Angiotensin System Studies 11
- Cardiovascular Health and Disease Prevention 8
- Surgery 46
- Lipoproteins and Cardiovascular Health 32
- Co-authors
- Neil R Poulter (62 shared papers)Eoin OʼBrien (16 shared papers)Gordon T. McInnes (16 shared papers)Hans Wedel (25 shared papers)Mark J. Caulfield (20 shared papers)Sverre E. Kjeldsen (10 shared papers)Rory Collins (9 shared papers)Jesper Mehlsen (9 shared papers)
- Journals
- Journal of Hypertension (25 papers)Journal of the Renin-Angiotensin-Aldosterone System (16 papers)Hypertension (12 papers)The Lancet (11 papers)European Heart Journal (10 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Peter Sever
191 papers receiving 16.6k citations
Peter Sever's Hit Papers
Peers
Comparison fields: 5 of 161
- Cardiology and Cardiovascular Medicine 8.3k
- Endocrinology, Diabetes and Metabolism 4.0k
- Surgery 5.9k
- Family Practice 181
- Geriatrics and Gerontology 280
Countries citing papers authored by Peter Sever
This map shows the geographic impact of Peter Sever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sever more than expected).
Fields of papers citing papers by Peter Sever
This network shows the impact of papers produced by Peter Sever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sever. The network helps show where Peter Sever may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Sever, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 195 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial Hit paper breakdown → | 2003 | 2830 |
| 2 | Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial Hit paper breakdown → | 2005 | 2007 |
| 3 | Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension Hit paper breakdown → | 2010 | 1306 |
| 4 | Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial Hit paper breakdown → | 2015 | 817 |
| 5 | Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Hit paper breakdown → | 2019 | 628 |
| 6 | British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary Hit paper breakdown → | 2004 | 614 |
| 7 | Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease Hit paper breakdown → | 2017 | 520 |
| 8 | Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke Hit paper breakdown → | 2010 | 497 |
| 9 | Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials Hit paper breakdown → | 2015 | 478 |
| 10 | Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension Hit paper breakdown → | 2007 | 464 |
| 11 | 2004 | 452 | |
| 12 | 2010 | 287 | |
| 13 | 1993 | 285 | |
| 14 | 2005 | 264 | |
| 15 | Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase Hit paper breakdown → | 2017 | 232 |
| 16 | 2012 | 217 | |
| 17 | 2005 | 215 | |
| 18 | Inflammatory and Cholesterol Risk in the FOURIER Trial Hit paper breakdown → | 2018 | 202 |
| 19 | 2001 | 199 | |
| 20 | 1981 | 182 |
About Peter Sever
Peter Sever is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism, Nutrition and Dietetics and Economics and Econometrics, having authored 195 papers that have together received 17.7k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (72 papers), Lipoproteins and Cardiovascular Health (32 papers), Hormonal Regulation and Hypertension (20 papers), Heart Rate Variability and Autonomic Control (15 papers), Sodium Intake and Health (11 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers), Renin-Angiotensin System Studies (11 papers) and Cardiovascular Health and Disease Prevention (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.3k citations), Endocrinology, Diabetes and Metabolism (4.0k citations), Surgery (5.9k citations), Family Practice (181 citations) and Geriatrics and Gerontology (280 citations). Peter Sever has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Neil R Poulter, Eoin OʼBrien, Gordon T. McInnes, Hans Wedel, Mark J. Caulfield, Sverre E. Kjeldsen, Rory Collins, Jesper Mehlsen, Markku S. Nieminen and Arni Kristinsson. Their work appears in journals such as Journal of Hypertension, Journal of the Renin-Angiotensin-Aldosterone System, Hypertension, The Lancet and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.